Gatitrip P Eye Drops contain Gatifloxacin 0.3% w/v and Prednisolone 1% w/v, a combination therapy for bacterial ocular infections with associated inflammation. The formulation effectively reduces redness, swelling, and irritation while controlling bacterial growth.
Gatifloxacin is a fluoroquinolone antibiotic that inhibits bacterial DNA gyrase and topoisomerase IV, thereby preventing bacterial replication. Prednisolone is a corticosteroid that reduces ocular inflammation, redness, and discomfort, providing rapid relief from symptomatic irritation.
Clinically, Gatitrip P Eye Drops are indicated for bacterial conjunctivitis, keratitis, blepharitis, and post-operative ocular inflammation. The ophthalmic drops are formulated for accurate dosing, high ocular penetration, and patient-friendly application, ensuring effective treatment outcomes.
Regular use under medical supervision helps in resolving infection, reducing inflammation, improving ocular comfort, and preventing complications. Gatitrip P Eye Drops is a trusted antibacterial and anti-inflammatory therapy, providing reliable management of bacterial eye infections with inflammation.